# Naloxegol Drug Utilization Post Authorisation Safety Study

> **NCT02813148** · — · COMPLETED · sponsor: **Kyowa Kirin Pharmaceutical Development Ltd** · enrollment: 17254 (actual)

## Conditions studied

- Opioid Induced Constipation

## Interventions

- **DRUG:** Naloxegol

## Key facts

- **NCT ID:** NCT02813148
- **Lead sponsor:** Kyowa Kirin Pharmaceutical Development Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08
- **Primary completion:** 2019-06
- **Final completion:** 2020-01
- **Target enrollment:** 17254 (ACTUAL)
- **Last updated:** 2024-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02813148

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02813148, "Naloxegol Drug Utilization Post Authorisation Safety Study". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02813148. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*